- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 34.24M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.1B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.08B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.49B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.29B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $3.83B |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $3.76B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.76B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.33B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $13.15B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.83B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $9.17B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.52B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $13.96B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $13.32B |
| Stock Repurchased | Q1 2025 · Feb 26, 2025 | $750M |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $73.6M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $595.8M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $779.6M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 42.4M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $34M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$153.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.78B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.82B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.55 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.57 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $88.5M |
| Net Income | Q1 2025 · Mar 31, 2024 | $65.8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $164.5M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $267.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $469.4M |